METHODS FOR IMPROVED HOMOLOGOUS RECOMBINATION AND COMPOSITIONS THEREOF

    公开(公告)号:WO2019051237A1

    公开(公告)日:2019-03-14

    申请号:PCT/US2018/049966

    申请日:2018-09-07

    Abstract: The present disclosure relates to methods, kits, and compositions for improving the efficiency of homologous recombination. In particular, the disclosure relates to methods for cloning DNA molecules directly into a genome with the combined use of promoter trapping and short homology arms, nuclear localization signal, and/or binding one or more DNA binding agents (TAL effector domain or truncated guide RNA bound by Cas9) to specific sites thereby displacing or restructuring chromatin at the target locus, and/or it increasing the accessibility of the target locus to further enzymatic modifications. The methods and compositions provided herein are, inter alia, useful for genome editing and enhancing enzymatic processes involved therein.

    GENE EDITING REAGENTS WITH REDUCED TOXICITY
    4.
    发明申请
    GENE EDITING REAGENTS WITH REDUCED TOXICITY 审中-公开
    具有降低毒性的基因编辑试剂

    公开(公告)号:WO2017184799A1

    公开(公告)日:2017-10-26

    申请号:PCT/US2017/028482

    申请日:2017-04-20

    Abstract: The present disclosure generally relates to compositions and methods for the genetic modification of cells. In particular, the disclosure relates to CRISPR reagents and the use of such reagents. Further disclosed are nucleic acid compositions with reduced cytotoxicity.

    Abstract translation: 本公开总体上涉及用于细胞遗传修饰的组合物和方法。 特别地,本公开涉及CRISPR试剂和这些试剂的用途。 还公开了具有降低的细胞毒性的核酸组合物。

Patent Agency Ranking